Baseline serum concentrations of zinc, selenium, and prolactin in critically ill children
- PMID: 23392368
- PMCID: PMC3913275
- DOI: 10.1097/PCC.0b013e31827200f5
Baseline serum concentrations of zinc, selenium, and prolactin in critically ill children
Abstract
Objectives: To describe serum concentrations of zinc, selenium, and prolactin in critically ill children within 72 hours of PICU admission, and to investigate relationships between these immunomodulators and lymphopenia.
Design: An analysis of baseline data collected as part of the multicenter Critical Illness Stress Induced Immune Suppression (CRISIS) Prevention Trial.
Setting: PICUs affiliated with the Collaborative Pediatric Critical Care Research Network.
Patients: All children enrolled in the CRISIS Prevention Trial that had baseline serum samples available for analysis.
Interventions: None.
Measurements and main results: Of 293 critically ill children enrolled in the CRISIS Prevention Trial, 284 had baseline serum samples analyzed for prolactin concentration, 280 for zinc concentration, and 278 for selenium concentration within 72 hours of PICU admission. Lymphocyte counts were available for 235 children. Zinc levels ranged from nondetectable (< 0.1 μg/mL) to 2.87 μg/mL (mean 0.46 μg/mL and median 0.44 μg/mL) and were below the normal reference range for 235 (83.9%) children. Selenium levels ranged from 26 to 145 ng/mL (mean 75.4 ng/mL and median 74.5 ng/mL) and were below the normal range for 156 (56.1%) children. Prolactin levels ranged from nondetectable (< 1 ng/mL) to 88 ng/mL (mean 12.2 ng/mL and median 10 ng/mL). Hypoprolactinemia was present in 68 (23.9%) children. Lymphopenia was more likely in children with zinc levels below normal than those with zinc levels within or above the normal range (82 of 193 [42.5%] vs. 10 of 39 [25.6%], p = 0.0498). Neither selenium nor prolactin concentrations were associated with lymphopenia (p = 1.0 and p = 0.72, respectively).
Conclusions: Serum concentrations of zinc, selenium, and prolactin are often low in critically ill children early after PICU admission. Low serum zinc levels are associated with lymphopenia, whereas low selenium and prolactin levels are not. The implications of these findings and the mechanisms by which they occur merit further study.
Conflict of interest statement
The authors have not disclosed any potential conflicts of interest.
Figures
Comment in
-
Enigma of low-serum zinc, selenium, and prolactin with lymphopenia.Pediatr Crit Care Med. 2013 May;14(4):443-5. doi: 10.1097/PCC.0b013e3182760687. Pediatr Crit Care Med. 2013. PMID: 23648879 No abstract available.
-
Zinc deficiency in systemic inflammatory response syndrome: cause or consequence?Pediatr Crit Care Med. 2013 Jul;14(6):654. doi: 10.1097/PCC.0b013e318291811f. Pediatr Crit Care Med. 2013. PMID: 23823205 No abstract available.
-
The authors reply.Pediatr Crit Care Med. 2013 Jul;14(6):655. doi: 10.1097/PCC.0b013e318297595c. Pediatr Crit Care Med. 2013. PMID: 23823206 No abstract available.
References
-
- Mizock BA. Immunonutrition and critical illness: An update. Nutrition. 2010;26:701–707. - PubMed
-
- Carcillo JA, Dean JM, Holubkov R, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Collaborative Pediatric Critical Care Research Network (CPCCRN): The randomized comparative pediatric critical illness stress-induced immune suppression (CRISIS) prevention trial. Pediatr Crit Care Med. 2012;13:165–173. - PMC - PubMed
-
- Garner JS, Jarvis WR, Emori TG, et al. CDC definitons of nosocomial infections. In: Olmsted RN, editor. APIC Infection Control and Applied Epidemiology: Principles and Practice. St. Louis, MO: Mosby; 1996. pp. A1–A20.
-
- Doughty L, Carcillo JA, Kaplan S, et al. The compensatory anti-inflammatory cytokine interleukin 10 response in pediatric sepsis-induced multiple organ failure. Chest. 1998;113:1625–1631. - PubMed
-
- Leteurtre S, Martinot A, Duhamel A, et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: Prospective, observational, multicentre study. Lancet. 2003;362:192–197. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U10HD049945/HD/NICHD NIH HHS/United States
- U10 HD050012/HD/NICHD NIH HHS/United States
- U10 HD049945/HD/NICHD NIH HHS/United States
- U10HD049981/HD/NICHD NIH HHS/United States
- UG1 HD049983/HD/NICHD NIH HHS/United States
- UG1 HD050096/HD/NICHD NIH HHS/United States
- U10 HD049981/HD/NICHD NIH HHS/United States
- U10 HD050096/HD/NICHD NIH HHS/United States
- U10 HD049983/HD/NICHD NIH HHS/United States
- RL1 HD107773/HD/NICHD NIH HHS/United States
- R01 HD073362/HD/NICHD NIH HHS/United States
- U10HD050096/HD/NICHD NIH HHS/United States
- U10HD049983/HD/NICHD NIH HHS/United States
- UG1 HD049981/HD/NICHD NIH HHS/United States
- U10HD050012/HD/NICHD NIH HHS/United States
- U01HD049934/HD/NICHD NIH HHS/United States
- UL1 TR000005/TR/NCATS NIH HHS/United States
- U01 HD049934/HD/NICHD NIH HHS/United States
- U10HD500009/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
